If your energy has flattened, your waistline keeps creeping up, and your last lab panel showed both a rising blood sugar and a low testosterone reading, you may feel like your body is working against you on two fronts at once. That frustration is real, and you are not imagining the link between the two numbers. Insulin resistance and low testosterone are not separate problems that happened to land on the same lab sheet. They tend to travel together, and each one can quietly make the other harder to fix.
The good news is that this connection cuts both ways, which means there is more than one place to intervene. To make sense of it, you need to understand how insulin resistance and low testosterone influence each other, what the recent evidence actually shows, and what that means for the conversation you have with your own doctor.
What Does Insulin Resistance Have to Do With Testosterone?
Insulin resistance means your cells have stopped responding well to insulin, so your body releases more of it to keep blood sugar in range. Over time this pattern is closely tied to extra fat around the organs (visceral fat), and that fat is far from inert. It behaves like an active hormone-producing tissue.
Part of what visceral fat does is convert testosterone into estradiol through an enzyme called aromatase. For years the popular explanation stopped there, with the idea that rising estrogen simply switches off the brain’s signal to the testes. However, the picture is more nuanced than that. A 2019 review in Andrology describes the relationship between obesity, dysglycemia, and low testosterone as bidirectional, and notes that suppression of the brain-testis (hypothalamic-pituitary-testicular) axis is mostly functional and potentially reversible, driven largely by inflammation rather than estrogen excess alone[1].
That distinction matters to you because “functional and potentially reversible” is a hopeful phrase. It means the suppression is not necessarily permanent.
How Low Testosterone Can Worsen Your Metabolism
The connection runs in the other direction too. Testosterone helps your body stay sensitive to insulin and supports the lean muscle that pulls glucose out of your bloodstream. When testosterone sits low, that metabolic support weakens, blood sugar tends to stay higher, and your body compensates with still more insulin. You can see how a loop forms.
A 2026 review in EBioMedicine reinforces this association, noting that low testosterone levels are linked with cardiovascular risk factors such as insulin resistance and arterial stiffness[2]. “Linked with” is the honest phrase here. The science points to a strong two-way association, not a guarantee that one number dooms the other.
There is an important caveat worth understanding. A 2020 review in the European Journal of Endocrinology points out that many men with obesity show low total testosterone largely because their sex hormone-binding globulin is low, and that these readings often improve with weight loss on their own[3]. In other words, a single low total testosterone result does not automatically mean you are testosterone deficient, which is exactly why interpretation belongs with a clinician. If you want to understand this further, see our guide to free versus total testosterone.
Can Treating One Improve the Other?
This is the question that matters most, and here the evidence is genuinely encouraging.
The Moscow Study, a randomized, placebo-controlled trial of 184 men with metabolic syndrome and hypogonadism, looked at what happens to insulin resistance when testosterone is restored. Among men not taking glucose-lowering drugs, those treated with testosterone undecanoate saw their HOMA-IR (a standard marker of insulin resistance) fall significantly compared with baseline, while placebo produced no meaningful change. Fasting insulin dropped by about 35.5% by 138 weeks (roughly three years), with a smaller fall in fasting glucose[4]. The authors concluded that screening for low testosterone deserves a place in managing men with metabolic syndrome and type 2 diabetes.
A separate one-year randomized trial in obese hypogonadal men with type 2 diabetes found similar movement, with testosterone therapy reducing HOMA-IR and lowering HbA1c compared with placebo[5].
What’s more, these findings sit alongside a major safety update. In 2025, the FDA removed the older cardiovascular boxed warning from testosterone product labels after reviewing TRAVERSE, while adding blood pressure warnings for testosterone products.[6] That single change captures the spirit of good care here: testosterone therapy can be reasonable for the right patient under monitoring, but it is not a shortcut and it carries clinical risks. You can read the fuller picture in our overview of TRT and cardiovascular risk after TRAVERSE.
None of this means testosterone therapy is a weight-loss shortcut. The reviews above are careful on that point, and so are we.
Practical Steps You Can Discuss With Your Doctor
Breaking this cycle usually takes more than a prescription, and the most durable gains tend to come from the basics done consistently.
Lifestyle remains the foundation. Weight loss, better sleep, and resistance training all support both insulin sensitivity and your natural testosterone, and the reviews here repeatedly frame these measures as first-line. Building and keeping muscle is especially useful, because muscle is where a great deal of your glucose gets used.
It also helps to look at the full metabolic picture rather than a single hormone reading. Asking your clinician about fasting insulin, HbA1c, and how your testosterone is measured (such as free testosterone alongside total) gives a far more honest view than any one number on its own.
What you should not do is self-diagnose from a symptom list or start any hormone therapy on your own. Testosterone therapy carries real considerations, such as the blood-pressure effect noted above, and it belongs in a monitored plan built with a doctor who knows your history.
Conclusion
Insulin resistance and low testosterone are connected in a genuine, two-way relationship, where each can make the other more stubborn. However, the same two-way link is also why there is real room for progress. Much of the hormonal suppression tied to metabolic problems appears functional and potentially reversible, lifestyle change addresses both sides at once, and for carefully selected men, restoring testosterone can improve markers of insulin resistance under proper supervision. The most useful step is to stop treating these as two unrelated problems and bring the whole picture to a clinician who can interpret it with you.
References
- [1] Grossmann M et al., Andrology. 2019, PMID 31502758
- [2] Andersen ML et al., EBioMedicine. 2026, PMID 41708399
- [3] Lapauw B, Kaufman JM. Eur J Endocrinol. 2020, PMID 33105105
- [4] Tishova Y et al., Diabetes Obes Metab. 2024, PMID 38433502
- [5] Groti K et al., Aging Male. 2018, PMID 29708829
- [6] FDA. Class-wide labeling changes for testosterone products. 2025.
